insights_auto
Why is DRUG down 3,58%?
Dive Deeperchevron_right
DRUG:CNSX
Bright Minds Biosciences Inc
72,00 CAD
arrow_downward
-3,58%(-2,67) 1D
14-окт., 09:37:39 GMT-4 · CAD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DRUG...
Open
72,00 CAD
High
72,00 CAD
Low
72,00 CAD
Mkt. cap
710,21 млн
Avg. vol.
848,00
Volume
103,00
52-wk high
170,00 CAD
52-wk low
68,02 CAD
EPS
-2,90 CAD
No. of employees
26
Open
72,00 CAD
High
72,00 CAD
Low
72,00 CAD
Mkt. cap
710,21 млн
Avg. vol.
848,00
Volume
103,00
52-wk high
170,00 CAD
52-wk low
68,02 CAD
EPS
-2,90 CAD
No. of employees
26
News stories
From web sources and news partners
Profile
Bright Minds Biosciences is an American pharmaceutical company which is developing serotonin 5-HT₂ receptor agonists for potential medical use.
It has a particular focus on serotonin 5-HT2C receptor agonists, for instance to treat rare epilepsies and other conditions. Another area of focus for the company is serotonergic psychedelics and non-hallucinogenic psychoplastogens.
The company was co-founded by Ian McDonald and Gideon Shapiro. The lead scientist at Bright Minds Biosciences was previously Alan Kozikowski. Bright Mind Biosciences was founded in 2017 and its headquarters are in New York City, New York. Wikipedia
About Bright Minds Biosciences Inc